Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVaccinex, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Vaccinex, Inc. Earnings Date And Information
Vaccinex, Inc. last posted its earnings results on Monday, August 16th, 2021. The company reported $-44.1 earnings per share for the quarter, topping analysts' consensus estimates of $-60.89 by $16.79. The company had revenue of 52,000 for the quarter and had revenue of 570,000 for the year. Vaccinex, Inc. has generated $-44 earnings per share over the last year ($-43.68 diluted earnings per share) and currently has a price-to-earnings ratio of -0.13. Vaccinex, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Vaccinex, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$2.83 | $52,000 | $52,000 | ||
| 08/14/2024 | Q2 2024 | -$3.10 | $232,000 | $232,000 | ||
| 05/15/2024 | Q1 2024 | -$2.94 | $104,000 | |||
| 04/25/2024 | Q4 2023 | -$8.44 | $-386,000 | |||
| 11/13/2023 | Q3 2023 | -$15.26 | $20,000 | |||
| 08/14/2023 | Q2 2023 | -$25.20 | $0 | |||
| 05/15/2023 | Q1 2023 | -$20.90 | $550,000 | |||
| 03/31/2023 | Q4 2022 | -$23.08 | $50,000 | |||
| 11/14/2022 | Q3 2022 | -$23.42 | $50,000 | |||
| 08/15/2022 | Q2 2022 | -$27.21 | $0 | |||
| 05/16/2022 | Q1 2022 | -$25.21 | $0 | |||
| 03/31/2022 | Q4 2021 | -$32.41 | $850,000 | |||
| 11/08/2021 | Q3 2021 | -$35.49 | $50,000 | |||
| 08/16/2021 | Q2 2021 | -$60.89 | -$43.86 | 17.03 | $0 | |
| 05/17/2021 | Q1 2021 | -$81.89 | -$54.75 | 27.14 | $850,000 | |
| 03/31/2021 | Q4 2020 | -$0.37 | -$60.46 | -60.09 | $50,000 | |
| 11/13/2020 | Q3 2020 | -$111.29 | -$91.57 | 19.72 | $630,000 | $50,000 |
| 08/14/2020 | Q2 2020 | -$107.09 | -$81.80 | 25.29 | $50,000 | $0 |
| 05/14/2020 | Q1 2020 | -$102.89 | -$93.83 | 9.06 | $0 | |
| 03/09/2020 | Q4 2019 | -$109.19 | -$89.86 | 19.33 | $0 |
Vaccinex, Inc. Earnings: FAQ's
When is Vaccinex, Inc.'s earnings date?
Vaccinex, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
Did Vaccinex, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Vaccinex, Inc. (:VCNX) reported $-44.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-60.89 by $16.79.
How can I listen to Vaccinex, Inc.'s earnings conference
call?
The conference call for Vaccinex, Inc.'s latest earnings report can be listened to online.
How can I read Vaccinex, Inc.'s conference call transcript?
The conference call transcript for Vaccinex, Inc.'s latest earnings report can be read online.
How much revenue does Vaccinex, Inc. generate each year?
Vaccinex, Inc. (:VCNX) has a recorded annual revenue of $570,000.
How much profit does Vaccinex, Inc. generate each year?
Vaccinex, Inc. (:VCNX) has a recorded net income of $570,000. Vaccinex, Inc. has generated $-43.68 earnings per share over the last four quarters.
What is Vaccinex, Inc.'s price-to-earnings ratio?
Vaccinex, Inc. (:VCNX) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is -0.